Cardiogenesis Announces Preliminary Clinical Results With The PHOENIX System Combining TMR + Stem Cells

Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products for cardiac revascularization, today announced a scientific presentation that describes the use of the PHOENIX delivery system combining transmyocardial revascularization (TMR) with autologous bone marrow derived stem cells.

More: continued here

Filed under: Stem Cell Research on June 19th, 2008